Atea Pharmaceuticals Inc (AVIR)
3.25
+0.09
(+2.85%)
USD |
NASDAQ |
Nov 21, 16:00
3.24
-0.01
(-0.31%)
After-Hours: 20:00
Atea Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
--
Maximum
Dec 2020
--
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| McKesson Corp | -1.904 |
| Pfizer Inc | 0.7219 |
| Doximity Inc | 0.00 |
| Immuneering Corp | -- |
| CEL-SCI Corp | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 490.96M |
| Total Liabilities (Quarterly) | 32.44M |
| Shareholders Equity (Quarterly) | 458.52M |